Cannatonic Strain.
Cannatonic Strain is an even blend of sativa and indica (50:50 sativa/indica ratio). It’s a great medical strain high in CBD, a chemical used to treat severe seizures and other conditions.
But it’s very low in THC 7–15% at most – so Cannatonic isn’t a good bet for getting high, despite its name. The high, such as it is, is relaxed and uplifting with both mental and physical qualities. This relaxation will soon spread throughout your entire body, helping you to stretch out and kick back without causing any sedation or sleepiness whatsoever. In combination with its low 7-8% average THC level and super high 12-14% CBD level, these soothing effects make Cannatonic the perfect highly medicinal choice for treating chronic pain, cramps or muscle spasms, chronic stress or anxiety and headaches or migraines. This bud has a classic sweet and sour citrusy flavor with a spicy herbal exhale. The aroma is of freshly turned woody earth with hints of spicy herbs and super sour lemons. Cannatonic buds have long and narrow olive green nugs with thick yellow-orange hairs and a coating of frosty chunky white crystal trichomes.
Cannatonic has an earthy smell, with a woody citrus flavor. It’s most popular in the Pacific Northwest, California, and Michigan. This strain is best for treating epilepsy and pain, as it provides a deep feeling of relaxation with uplifting cerebral effects.
Cannatonic is a hybrid blend of MK Ultra, an indica, and the legendary G-13 Haze, an indica-dominant hybrid. The strain was bred to produce a greater ratio of sativa to indica, and that helps keep the head high clear. Possible side effects include dry mouth, while anxiety and paranoia are less likely.
Cannatonic Strain
sensations
Reported by 848 real people like you
Strain effects
Feelings
relaxed
focused
sleepy
Strain flavors
woody
spicy/herbal
pine
Cannatonic Strain
helps with
-
-
47% of people say it helps with pain
-
Stress43% of people say it helps with stress
-
Anxiety41% of people say it helps with anxiety
-
Reviews
There are no reviews yet.